MedPath

KSHARA KARMA IN NADI VRANA

Not yet recruiting
Conditions
Pilonidal cyst and sinus with abscess. Ayurveda Condition: NADIVRANAH,
Registration Number
CTRI/2020/12/030116
Lead Sponsor
SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL
Brief Summary

THIS STUDY IS AN OPEN LABEL TWO ARM NON RANDOMIZED COMPARATIVE STUDY.PATIENTS WILL BE SELECTED IN CONVIENIENT METHOD.

THERE WILL BE TWO GROUPS TO BE COMPARED.ONE WILL BE MANAGED BY APAMARGA PRATISARANEEYA KSHARA(CONTROL GROUP) AND OTHER WITH AGNIMANTHA PRATISARANEEYA KSHARA(TRIAL GROUP) FOLLOWED BY DAILY DRESSING WITH JATHYADI TAILA FOR SEVEN DAYS AND A FOLLOW UP PERIOD OF 2 MONTHS.

THE STUDY WILL BE CONDUCTED IN HOSPITAL ATTACHED TO AYURVEDA MEDICAL COLLEGE WITH LABORATORY FACILITIES

OUTCOME IS ASSESSED BY COMPLETE HEALING OF WOUND ALONG WITH REDUCTION IN PREVIOUS SYMPTOMS AND NON RECCURANCE FOR A PERIOD OF 2 MONTHS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

SUBJECTS HAVING SIGNS AND SYMPTOMS OF NADI VRANA(PILONIDAL SINUS) SUBJECTS WITH WRITTEN SURGICAL CONSENT SUBJECTS OF EITHER GENDER,RELIGION ,SOCIO ECONOMIC STATUS.

Exclusion Criteria

UNCONTROLLED DIABETES(HbA1c>7) KOCK,S DISEASE OSTEOMYELITIS HIV HBSAG PREGNANCY CARCINOMA SINUS WITH MULTIPLE OPENING SEVERE SYSTEMIC ILLNESS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COMPLETE WOUND HEALINGBASELINE,4 WEEKS,8 WEEKS,12 WEEKS
NON REOCCURANCE OF PILONIDAL SINUSBASELINE,4 WEEKS,8 WEEKS,12 WEEKS
Secondary Outcome Measures
NameTimeMethod
NON RECCURANCE OF PILONIDAL SINUS2 MONTHS

Trial Locations

Locations (1)

OPD AND IPD OF DEPT OF SHALYA TANTRA

🇮🇳

Hassan, KARNATAKA, India

OPD AND IPD OF DEPT OF SHALYA TANTRA
🇮🇳Hassan, KARNATAKA, India
DR ANANYA
Principal investigator
8951757564
ananyaranganth@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.